Stuart Poulton serves as Executive at Karyopharm Therapeutics Inc., where they oversee executive responsibilities. Since joining the company, Stuart Poulton has executed 16 insider transactions totaling $64.3K, demonstrating a bearish approach to their equity position. Their most recent transaction on Oct 15, 2025 involved receiving (via award) 39,682 shares valued at $0.
Stuart Poulton currently holds 67,392 shares of Karyopharm Therapeutics Inc. (KPTI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Stuart Poulton has been a net seller of KPTI stock. They have purchased $0 and sold $64.3K worth of shares.
Stuart Poulton's most recent insider trade was on Oct 15, 2025, when they sold 39,682 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $6.43 |
| Discretionary |
| Sep 12, 2025 | KPTI | $0 | Award | 888 | $N/A | Discretionary |
| Jul 29, 2025 | KPTI | $835 | Sale | 191 | $4.37 | Discretionary |
| Jul 30, 2024 | KPTI | $3.1K | Sale | 2,883 | $1.06 | Discretionary |
| Mar 1, 2024 | KPTI | $7.4K | Sale | 6,155 | $1.20 | Discretionary |
| Feb 29, 2024 | KPTI | $19.1K | Sale | 16,311 | $1.17 | Discretionary |
| Feb 28, 2024 | KPTI | $0 | Award | 188,205 | $N/A | Discretionary |
| Feb 15, 2024 | KPTI | $139 | Sale | 99 | $1.40 | Discretionary |
| Feb 15, 2024 | KPTI | $7.6K | Sale | 5,748 | $1.33 | Discretionary |
| Jan 24, 2024 | KPTI | $0 | Award | 13,333 | $N/A | Discretionary |
| Jul 28, 2023 | KPTI | $4.8K | Sale | 2,845 | $1.70 | Planned |
| Feb 28, 2023 | KPTI | $0 | Award | 95,000 | $N/A | Discretionary |
| Feb 15, 2023 | KPTI | $18.1K | Sale | 5,665 | $3.19 | Discretionary |
| Feb 15, 2023 | KPTI | $619 | Sale | 196 | $3.16 | Discretionary |
| Feb 15, 2023 | KPTI | $26 | Sale | 8 | $3.23 | Discretionary |